These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3798863

  • 1. Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.
    Leen CL, Yap PL, McClelland DB.
    Vox Sang; 1986; 51(4):278-86. PubMed ID: 3798863
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patients.
    Ebeling F, Baer M, Hormila P, Järventie G, Koistinen P, Kätkä K, Oksanen K, Perkkiö M, Ruutu T, Soppi E.
    Vox Sang; 1995; 69(2):91-4. PubMed ID: 8585206
    [Abstract] [Full Text] [Related]

  • 7. The long term treatment of childhood hypogammaglobulinaemia in Melbourne with intravenous gammaglobulin, 1972-1985.
    Roberton DM, Hosking CS.
    Dev Biol Stand; 1987; 67():273-80. PubMed ID: 2440742
    [Abstract] [Full Text] [Related]

  • 8. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
    Orange JS, Grossman WJ, Navickis RJ, Wilkes MM.
    Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies.
    Gustafson R, Gardulf A, Hansen S, Leibl H, Engl W, Lindén M, Müller A, Hammarström L.
    Clin Exp Immunol; 2008 May; 152(2):274-9. PubMed ID: 18341618
    [Abstract] [Full Text] [Related]

  • 12. Penetration of administered IgG into the maxillary sinus and long-term clinical effects of intravenous immunoglobulin replacement therapy on sinusitis in primary hypogammaglobulinaemia.
    Williams P, White A, Wilson JA, Yap PL.
    Acta Otolaryngol; 1991 May; 111(3):550-5. PubMed ID: 1887782
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S, Bernatowska E, de Gracia J, Borte M, Cristea V, Peter HH, Belohradsky BH, Wahn V, Neufang-Hüber J, Zenker O, Grimbacher B.
    Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study.
    Gardulf A, Nicolay U, Asensio O, Bernatowska E, Böck A, Carvalho BC, Granert C, Haag S, Hernández D, Kiessling P, Kus J, Pons J, Niehues T, Schmidt S, Schulze I, Borte M.
    J Clin Immunol; 2006 Mar; 26(2):177-85. PubMed ID: 16758340
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decreased incidence of adverse infusion reactions in hypogammaglobulinemic children receiving low pH intravenous immunoglobulin.
    Roberton DM, Hosking CS, Efthimiou H, Wright S, Upton H, Colgan T, Hartman L, Schiff P.
    Aust N Z J Med; 1987 Oct; 17(5):495-500. PubMed ID: 3446162
    [Abstract] [Full Text] [Related]

  • 19. Clinical use of a new pH 4.25 intravenous immunoglobulin preparation (gamimune-N).
    Pirofsky B.
    J Infect; 1987 Jul; 15 Suppl 1():29-37. PubMed ID: 3117898
    [Abstract] [Full Text] [Related]

  • 20. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
    Chapel H, Griffiths H, Brennan V, Bunch C, Lea J, Lee M.
    Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.